Cabozantinib impurity 1DYH Chemical Properties

Density 

1.36±0.1 g/cm3(Predicted)

pka

13.86±0.70(Predicted)

Cabozantinib impurity 1DYH Usage And Synthesis

Uses

Cabozantinib N-oxide is a impurity of Cabozantinib (X745500), a medication used to treat medullary thyroid cancer. As well, it can be used in biological study. Computational network biological approach based on pathway cross-talk inhibition identified new synergistic drug combinations using raloxifene and cabozantinib for treatment of human breast cancer in xenograft mouse model. Potent c-MET inhibitor.

Cabozantinib impurity 1DYH(1621681-63-7)Related Product Information

• Cabozantinib Impurity EXA
• 1-(4-Fluorophenylcarbamoyl)cyclopropanecarboxylic acid
• Cyclopropanecarboxylic acid, 1-[[[4-[[7-methoxy-6-(sulfooxy)-4-quinolinyl]oxy]phenyl]amino]carbonyl]-
• 1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl-
• Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)-
• Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]-
• Cabozantinib Malate
• 1,1-Cyclopropanedicarboxamide, N,N'-bis[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-
• Cyclopropanecarboxylic acid, 1-[[(2-fluorophenyl)amino]carbonyl]-
• Sunitinib
• Lapatinib
• Cabozantinib
• LOXO-101
• Dasatinib
• Cabozantinib Impurity DM
• 1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl-
• N,N'-Bis(4-hydroxyphenyl)hydrazine
• Cabozantinib impurity DX2